Hims & Hers Health (HIMS) Deferred Taxes (2021 - 2026)
Hims & Hers Health (HIMS) reported Deferred Taxes of -$14.0 million for Q1 2026, down 1470.22% on a YoY basis from $1.0 million in Q1 2025, and down 301.93% sequentially from -$3.5 million in Q4 2025.
Hims & Hers Health (HIMS) Deferred Taxes (2021 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 6 years of Deferred Taxes data on file, last reported at -$14.0 million in Q1 2026.
- For the quarter ending Q1 2026, Deferred Taxes fell 1470.22% year-over-year to -$14.0 million; the trailing twelve-month figure through Mar 2026 stood at -$26.0 million (up 58.35% YoY), and the FY2025 full-year result was -$13.0 million, up 78.98% from the prior year.
- Deferred Taxes fell to -$14.0 million in Q1 2026, from -$3.5 million in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $862000.0 in Q3 2025 to a low of -$54.3 million in Q3 2024.
- A 5-year average of -$5.2 million and a median of -$122000.0 in 2022 frame the typical range for Deferred Taxes.
- Across the five-year window, Deferred Taxes jumped 143.75% in 2023 and plunged 945700.0% in 2025, its largest moves.
- Tracing HIMS's Deferred Taxes over 5 years: stood at -$214000.0 in 2022, then soared by 107.94% to $17000.0 in 2023, then sank by 43094.12% to -$7.3 million in 2024, then soared by 52.43% to -$3.5 million in 2025, then sank by 301.93% to -$14.0 million in 2026.
- Business Quant data shows HIMS's Deferred Taxes at -$14.0 million in Q1 2026, -$3.5 million in Q4 2025, and $862000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | -22.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 34.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 25.90 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -69.70 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | -61.10 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | - |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn | -13.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.98 Mn |
| Dec 31, 2025 | -3.48 Mn |
| Sep 30, 2025 | 862,000.00 |
| Jun 30, 2025 | -9.46 Mn |
| Mar 31, 2025 | -890,000.00 |
| Dec 31, 2024 | -7.31 Mn |
| Sep 30, 2024 | -54.34 Mn |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Sep 30, 2023 | -10,000.00 |
| Jun 30, 2023 | -69,000.00 |
| Mar 31, 2023 | 49,000.00 |
| Dec 31, 2022 | -214,000.00 |
| Sep 30, 2022 | -122,000.00 |
| Jun 30, 2022 | -146,000.00 |
| Mar 31, 2022 | -112,000.00 |
| Dec 31, 2021 | -210,000.00 |
| Sep 30, 2021 | -3.18 Mn |